U.S. bars federal funding of gender transitions for low-income minors
The U.S. government has finalized a rule barring Medicaid and CHIP from funding gender-affirming care for minors, citing concerns over long-term health risks. The policy, effective in October, shifts the financial burden for these treatments to states and private insurance.
Why it matters
This represents a significant shift in U.S. healthcare policy regarding transgender youth, impacting access for millions of low-income children.
The U.S. government finalised a rule on Tuesday (August 11, 2026) barring two major federal health programmes from funding puberty blockers, hormone therapy and surgeries to treat gender dysphoria in minors, reshaping access for low-income youth nationwide.
The rule, scheduled for publication on Thursday (August 13) and effective in October, cuts off funding under Medicaid and the Children’s Health Insurance Program, or CHIP, which together cover 35.5 million U.S. children.
Roughly a decade after U.S. speciality clinics began offering pediatric gender treatments, the government says it will no longer share the cost for children under 18 in Medicaid and under 19 in CHIP, citing what it called weak evidence of benefit and risks of irreversible harm.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in